Navigation Links
HeartWare to Present at Seventh Annual JMP Securities Research Conference
Date:5/14/2008

FRAMINGHAM, Mass., and SYDNEY, Australia, May 14 /PRNewswire-FirstCall/ -- HeartWare Limited (ASX: HTW) today announced that it is scheduled to make an investor presentation at the Seventh Annual JMP Securities Research Conference at 9:30 a.m. PT (12:30 p.m. ET) on Wednesday, May 21, 2008. The conference is being held at the Ritz-Carlton, San Francisco May 19-21.

A live webcast of the Company's presentation at the conference will be available via a link provided at http://www.heartware.com. An archived replay of the presentation will be available shortly after the presentation time for a period of 90 days.

About HeartWare

HeartWare develops and manufactures miniaturized implantable heart pumps, or Left Ventricular Assist Devices, designed to treat patients suffering from advanced heart failure. The Company is developing smaller and less invasive pumps, which it believes will be the key to unlocking the potential of a large and underserved market. The HeartWare(R) LVAS is a full-output pump designed to be implanted in the chest, avoiding the abdominal surgery generally required to implant competing devices. The pump is currently the subject of an international clinical trial involving five investigational centres in Europe and Australia. A clinical trial in the U.S. is expected to commence shortly following receipt of conditional approval of an IDE in early May 2008.

For further information:

http://www.heartware.com.au

Howard Leibman

Director Corporate Development

HeartWare Limited

Email. howard.leibman@heartware.com.au

Tel. +61 2 9238 2064

US Investor Relations

Matt Clawson

Partner

Allen & Caron, Inc.

Email. matt@allencaron.com

Tel. +1 9
'/>"/>

SOURCE HeartWare Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HeartWare Receives Conditional Approval of IDE
2. HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility
3. HeartWare Selects Allen & Caron for Investor Relations and Corporate Communications
4. Mindray to Present at the Oppenheimer 2nd Annual China Dragon Call Conference and 2008 Citi Investment Research Global Healthcare Conference
5. Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
6. Sunesis Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. China Sky One Medical, Inc. to Present at Brean Murray Carret & Co. All-Cap All-China Conference
8. EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference
9. Emphasys Medical to Present VENT Clinical Trial Data at ATS 2008
10. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
11. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 2Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 3Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 4Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 5Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 6Health News:The Female Health Company Reports First Quarter Operating Results, as Gross Profit Margins Widen on Increasing Sales of FC2 Female Condom(R) 7Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 2Health News:Cambridge Healthtech Media Group Launches Clinical Trials Web Site 3Health News:MainConcept Releases New Codec SDK 8.0 2Health News:MainConcept Releases New Codec SDK 8.0 3Health News:MainConcept Releases New Codec SDK 8.0 4Health News:Aetna Now Covers Novasys Medical's Renessa(R) Treatment for Incontinence in Women 2Health News:China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009 2Health News:Nothing But Nets and Union of Reform Judaism Help Save Lives in Kenya 2
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Within3 Expands into Mobile Applications 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 1New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 2New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 3New Data Demonstrate Magnetic Resonance Safety of AQUACEL 28R 29 Ag Dressing 55129 4Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 1Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 2Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 3Zipcar Wraps Up Month Long Program Reveals Results of the 2009 Low Car Diet 55127 4